NCT03818516View on ClinicalTrials.gov

Impact of Inflammation on Reward Circuits, Motivational Deficits and Negative Symptoms in Schizophrenia

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

August 31, 2020

Primary Completion Date

March 1, 2022

Study Completion Date

March 1, 2022

Conditions
Schizophrenia
Interventions
OTHER

Oral Glucose Tolerance Test (OGTT)

Participants will undergo a fasting blood draw for inflammatory and metabolic markers before a 75gm oral glucose tolerance test (OGTT) and at 1, 2 and 3 hours post-OGTT. Behavioral assessments will also be administered pre- and post-OGTT administration.

Trial Locations (6)

30030

Emory University Department of Psychiatry and Behavioral Sciences, Atlanta

30303

Grady Health System (non-CRN), Grady Health System (CRN), Ponce Center, Atlanta

30322

Emory Clinic, Emory University Hospital, Atlanta

Emory University Clinical Research Network, Atlanta

Emory University, Atlanta

Emory Universtiy, Atlanta

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Emory University

OTHER

NCT03818516 - Impact of Inflammation on Reward Circuits, Motivational Deficits and Negative Symptoms in Schizophrenia | Biotech Hunter | Biotech Hunter